The inquiry is looking into a politically explosive suggestion that Pfizer delayed announcing a successful vaccine against ...

Biotech company Immunai, which developed an AI-based immune system mapping technology for drug development, announces the ...

“Pharma continues turning to AI to better understand diseases and speed up drug discovery and development,” said Noam Solomon, Ph.D., CEO and co-founder of Immunai.

Andrew Baum, Pfizer's chief strategy and innovation officer, talked Thursday about the pharmaceutical company's drug ...

Pfizer has partnered with ... “We look forward to helping expedite research into novel therapeutics as our intelligent digital drug discovery and development platform continues to expand and ...

$10.8 billion invested in internal research and development projects, and Approximately $300 million invested in business development transactions. Returned capital directly to shareholders ...

Recently, Pfizer has concentrated on expanding its oncology segment, enhanced by the March 2023 acquisition of Seagen. This focus on oncology highlights the importance of research and development ...

Pfizer is going "all in" to develop its ... as well as its disappointing internal research and development operations.

In this article, we are going to take a look at where Pfizer Inc. (NYSE ... wide range of companies that provide patient care, research and development of new medicines, and design, manufacture ...

Pfizer has partnered with ... “We look forward to helping expedite research into novel therapeutics as our intelligent digital drug discovery and development platform continues to expand and ...